ABL Bio Inc Total Liabilities

Latest as of June 2026: ₩99.78 Billion KRW ≈ $67.62 Million USD

ABL Bio Inc total liabilities. Based on the latest financial reports, ABL Bio Inc (298380) has total liabilities worth ₩99.78 Billion KRW (≈ $67.62 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 298380 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of ABL Bio Inc (2016–2025)

Total liabilities of ABL Bio Inc from 2016 to 2025. This chart illustrates how ABL Bio Inc's total liabilities have evolved over time, based on quarterly financial data. Check 298380 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

ABL Bio Inc Competitors by Total Liabilities

The table below lists competitors of ABL Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Vardhman Textiles Limited NSE:VTL	India	Rs-105.88 Billion
Savaria Corporation TO:SIS	Canada	CA$458.82 Million
Metrovacesa SA MC:MVC	Spain	€843.82 Million
Sichuan Injet Electric Co Ltd SHE:300820	China	CN¥1.36 Billion
Investment and Industrial Development Joint Stock Corp VN:BCM	Vietnam	₫38.83 Trillion
Galapagos N.V. AS:GLPG	Netherlands	€119.06 Million
Milkyway Chemical Supply Chain Service Co Ltd SHG:603713	China	CN¥10.42 Billion
China Railway Construction Corporation Limited F:4FF	Germany	€1.70 Trillion

Liability Composition Analysis (2016–2025)

This chart breaks down ABL Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of ABL Bio Inc.

Liquidity & Leverage Metrics

ABL Bio Inc Total Liabilities Ratios Explained

ABL Bio Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.58	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ABL Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ABL Bio Inc (2016–2025)

The table below shows the annual total liabilities of ABL Bio Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩124.24 Billion ≈ $84.19 Million	+92.03%
2024-12-31	₩64.70 Billion ≈ $43.84 Million	-24.83%
2023-12-31	₩86.07 Billion ≈ $58.33 Million	-25.59%
2022-12-31	₩115.67 Billion ≈ $78.39 Million	+1117.57%
2021-12-31	₩9.50 Billion ≈ $6.44 Million	+2.93%
2020-12-31	₩9.23 Billion ≈ $6.25 Million	-15.28%
2019-12-31	₩10.89 Billion ≈ $7.38 Million	-8.50%
2018-12-31	₩11.91 Billion ≈ $8.07 Million	-88.80%
2017-12-31	₩106.32 Billion ≈ $72.05 Million	+441.66%
2016-12-31	₩19.63 Billion ≈ $13.30 Million	--

About ABL Bio Inc

KQ:298380 Korea Biotechnology

Market Cap

$1.56 Billion

₩2.30 Trillion KRW

Market Cap Rank

#6875 Global

#163 in Korea

Share Price

₩41000.00

Change (1 day)

-1.91%

52-Week Range

₩40550.00 - ₩245500.00

All Time High

₩245500.00